Bovie Medical (BVX) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Bovie Medical Corporation Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook
November 1, 2018 4:05 PM EDTAdvanced Energy Sales of $3.0 million in Q3, up 40% year-over-year and 92% year-to-date
CLEARWATER, Fla.--(BUSINESS WIRE)-- Bovie Medical Corporation (NYSEAMERICAN: BVX) (the Company), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today reported financial results for its third quarter ended September30, 2018.
Third Quarter 2018 Financial Summary:
Total Q3 revenue from continuing operations of approximately $3.7 million, up 39% year-over-year. Advanced Energy revenue of $3.0 million, up 40% year-over-year,... More